Background
Despite the diversity of HIV-1 variants in a chronically infected individual, during transmission, only a few variants seed new infections. These founder viruses predominantly utilize the CCR5 co-receptor to facilitate viral entry into CD4 T cells over the CXCR4 co-receptor. The host factors that contribute to this transmission bottleneck are not well understood. We have recently identified a host gene involved in glycosylation, SLC35A2, that restricts CXCR4-tropic (X4) viruses and enhances CCR5-tropic (R5) virus replication, which recapitulates the selection pattern observed in natural transmission. Preliminary data suggest SLC35A2 acts early in infection, but the exact stage is not known.
Methods
SLC35A2 was inactivated by CRISPR-Cas9 in primary CD4 T cells (SLC knockout, KO) and several early steps of viral replication were evaluated: (1) binding of HIV Gag-iGFP to cells by flow cytometry; (2) virus-cell fusion by the BlaM-Vpr fusion assay; (3) production of viral reverse transcription (RT) intermediates measured by qPCR. Unpaired t tests were used to determine significance of SLC KO compared to control cells.
Results
SLC35A2 inactivation resulted in an increase in iGFP virus binding of both the X4-tropic NL4-3 and the R5-tropic JRFL viruses as compared to control cells (log2FC = 2, p<0.05). Further, complementing SLC KO cells with exogenous SLC35A2 cDNA reduced binding to wildtype levels, suggesting this effect is specific to SLC35A2. We assessed fusion of the X4-tropic virus LAI and observed a 3.5-fold increase in fusion with SLC KO versus control cells across donors. Finally, after infection with Q23.BG505 (R5) virus, SLC KO cells had significantly reduced production of RT intermediates versus the control (log2FC = -4, p<0.05). Conversely, infecting with LAI (X4) led to an increase in RT intermediates in the SLC KO cells (log2FC = 3, p<0.05) compared to control cells.
Conclusions
Overall, these results suggest SLC35A2 acts early in viral replication. SLC35A2’s function alters binding of virions to the host receptor CD4, but that effect does not differ by tropism. The effect of SLC35A2 on viral fusion, which occurs through engagement with the CCR5 and/or CXCR4 co-receptors, is consistent with the differential infection we previously reported and might contribute to the HIV-1 transmission bottleneck.
Table or Figure
![]()